Investigation and pending class action against Eli Lilly in connection with its manufacturing and distribution of Zyprexa.
Zyprexa was FDA approved for the short-term treatment of acute manic episodes in bipolar disorder. The worlds best selling schizophrenia drug, Zyprexa sales account for 40% of Eli Lillys $11.08 billion in sales.
There have been many questions regarding the popular drug Zyprexa and its safety. Linked to 288 reported Zyprexa diabetes cases, including 23 deaths, the Zyprexa concerns were so great that Japan and the European Union required that diabetes warnings be included on Zyprexa labeling. The Public Citizen consumer group thinks the FDA has not adequately warned physicians and Zyprexa patients of the Zyprexa risks. Hyperglycemia, diabetes, and ketoacidosis have been reported amongst Zyprexa patients. Ketoacidosis, associated to Zyprexa adverse effects reports end up fatal in about 50% of the cases.
The last time the Zyprexa labeling was updated in the U.S. the FDA only made a quick reference to the risk of Zyprexa diabetes and hyperglycemia in the middle of the adverse reactions section of Zyprexa labeling.
Do not change medications without first consulting your doctor.
Name (Stock Symbol)
Eli Lilly & Company (LLY)
Eli Lilly and Company develops, manufactures, and sells pharmaceutical products.
The information provided on ClassAdvocate.com is general in nature,
does not apply to any particular factual situation, and is not and
should not be taken as legal or other professional advice. We make no
commitment or warranty that the factual, legal or any other information
on ClassAdvocate.com, or on any linked website, is accurate, complete,
error-free, or current. As such, you should not rely on such information,
and should seek professional advice if and as you determine appropriate.
ClassAdvocate.com is not a lawyer referral service, and no attorney-client
or confidential relationship is or should be formed by use of the site.
The investigations listed on ClassAdvocate.com are attorney advertisements
and do not in any way constitute a referral or endorsement by ClassAdvocate.com
or any approved or authorized lawyer referral service.